Attendees

Disease Modelling is crucial step in the pre-clinical phase of a clinical trial. The recent advances in models, ranging from induced-pluripotent stem cells, 3D organoids and patient-derived xenografts, has led to a revolution in the ability to study diseases, map their progression and accelerate the innovation of  therapies for neurodegenerative diseases, oncology and beyond. 

Join us and engage in a series of keynote presentations and panel discussions focusing on the latest topics in disease modelling, and connect with experts involved in the fields below, to discuss the application of models improving the understanding of disease progression and accelerating therapeutic development.